BioCentury
ARTICLE | Company News

Repligen management update

January 26, 2015 8:00 AM UTC

Repligen Corp. (NASDAQ:RGEN), Waltham, Mass. Business: Biomanufacturing, Supply/Service Retiring: Walter Herlihy as president and CEO, effective May 21; he is succeeded as CEO by COO Tony Hunt ...